- Home
- MLAB vs AVK Comparison
MLAB vs AVK Comparison
Compare MLAB & AVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MLAB | AVK |
|---|---|---|
| Founded | 1982 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.0M | 551.0M |
| IPO Year | 1995 | 2003 |
Fundamental Metrics
Financial Performance| Metric | MLAB | AVK |
|---|---|---|
| Price | $107.00 | $12.86 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $94.00 | N/A |
| AVG Volume (30 Days) | 114.9K | ★ 138.8K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.67% | N/A |
| EPS Growth | ★ 99.24 | N/A |
| EPS | ★ 1.95 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.07 | N/A |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | $54.92 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $59.63 | $10.77 |
| 52 Week High | $111.29 | $13.10 |
Technical Indicators
Market Signals| Indicator | MLAB | AVK |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 59.59 |
| Support Level | $94.01 | $12.50 |
| Resistance Level | $107.88 | $13.07 |
| Average True Range (ATR) | 5.12 | 0.19 |
| MACD | 0.19 | -0.02 |
| Stochastic Oscillator | 70.61 | 80.65 |
Price Performance
Historical ComparisonAbout MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About AVK Advent Convertible and Income Fund
Advent Convertible & Income Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in various sectors, such as communications, utilities, energy, industrial, technology, and others.